Research ExplorerScientific StaffKatja Weisel Publications

Prof.Dr.med. ID: 6488383

Katja Weisel

graph of relations
Affiliations
51 - 100 out of 260Page size: 50
Sort by: Title

Publications

  1. Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset

    Chari, A., Samur, M. K., Martinez-Lopez, J., Cook, G., Biran, N., Yong, K. L., Hungria, V. T. D. M., Engelhardt, M., Gay, F., Garcia-Feria, A., Oliva, S., Oostvogels, R., Gozzetti, A., Rosenbaum, C. A., Kumar, S. K., Stadtmauer, E., Einsele, H., Beksac, M., Weisel, K. C., Anderson, K. C., Mateos, M-V., Moreau, P., San Miguel, J., Munshi, N. C. & Avet-Loiseau, H., 06.11.2020, In: BLOOD.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  2. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma

    Martin, T., Krishnan, A., Yong, K., Weisel, K., Mehra, M., Nair, S., Qi, K., Londhe, A., Diels, J., Crivera, C., Jackson, C. C., Olyslager, Y., Vogel, M., Schecter, J. M., Banerjee, A., Valluri, S., Usmani, S. Z., Berdeja, J. G. & Jagannath, S., 02.2022, In: EJHaem. 3, 1, p. 97-108 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

    Moreau, P., Mateos, M-V., Gonzalez Garcia, M. E., Einsele, H., De Stefano, V., Karlin, L., Lindsey-Hill, J., Besemer, B., Vincent, L., Kirkpatrick, S., Delforge, M., Perrot, A., van de Donk, N. W. C. J., Pawlyn, C., Manier, S., Leleu, X., Martinez-Lopez, J., Ghilotti, F., Diels, J., Morano, R., Albrecht, C., Strulev, V., Haddad, I., Pei, L., Kobos, R., Smit, J., Slavcev, M., Marshall, A. & Weisel, K., 02.2024, In: ADV THER. 41, 2, p. 696-715 20 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

    Weisel, K., Martin, T., Krishnan, A., Jagannath, S., Londhe, A., Nair, S., Diels, J., Vogel, M., Schecter, J. M., Banerjee, A., Berdeja, J. G., Nesheiwat, T., Garrett, A., Qi, K., Valluri, S., Usmani, S. Z. & Yong, K., 01.2022, In: CLIN DRUG INVEST. 42, 1, p. 29-41 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

    Einsele, H., Moreau, P., Bahlis, N., Bhutani, M., Vincent, L., Karlin, L., Perrot, A., Goldschmidt, H., van de Donk, N. W. C. J., Ocio, E. M., Martinez-Lopez, J., Rodríguez-Otero, P., Dytfeld, D., Diels, J., Strulev, V., Haddad, I., Renaud, T., Ammann, E., Cabrieto, J., Perualila, N., Gan, R., Zhang, Y., Parekh, T., Albrecht, C., Weisel, K. & Mateos, M-V., 04.2024, In: ADV THER. 41, 4, p. 1576-1593 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Comparative Efficacy of Teclistamab Versus Current Treatments in Real-World Clinical Practice in the Prospective LocoMMotion Study in Patients with Triple-Class-Exposed Relapsed and/or Refractory Multiple Myeloma

    Moreau, P., van de Donk, N. W. C. J., Delforge, M., Einsele, H., De Stefano, V., Perrot, A., Besemer, B., Pawlyn, C., Karlin, L., Manier, S., Leleu, X., Weisel, K., Ghilotti, F., Diels, J., Elsada, A., Morano, R., Strulev, V., Pei, L., Kobos, R., Smit, J., Slavcev, M. & Mateos, M-V., 05.2023, In: ADV THER. 40, 5, p. 2412-2425 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma

    Mateos, M-V., Chari, A., Usmani, S. Z., Goldschmidt, H., Weisel, K., Qi, K., Londhe, A., Nair, S., Lin, X., Pei, L., Ammann, E., Kobos, R., Smit, J., Parekh, T., Marshall, A., Slavcev, M. & Moreau, P., 05.2023, In: CL LYMPH MYELOM LEUK. 23, 5, p. 385-393 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment

    Kriegsmann, K., Hundemer, M., Hofmeister-Mielke, N., Reichert, P., Manta, C-P., Awwad, M. H. S., Sauer, S., Bertsch, U., Besemer, B., Fenk, R., Hänel, M., Munder, M., Weisel, K. C., Blau, I. W., Neubauer, A., Müller-Tidow, C., Raab, M. S., Goldschmidt, H., Huhn, S. & For The German-Speaking Myeloma Multicenter Group Gmmg, 18.08.2020, In: CANCERS. 12, 8

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma

    Horger, M., Fritz, J., Thaiss, W. M., Ditt, H., Weisel, K., Haap, M. & Kloth, C., 03.2018, In: SKELETAL RADIOL. 47, 3, p. 351-361 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma

    Schieferdecker, A., Hörber, S., Ums, M., Besemer, B., Bokemeyer, C., Peter, A. & Weisel, K., 09.01.2020, In: BLOOD CANCER J. 10, 1, p. 2

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

    Weinhold, N., Kirn, D., Seckinger, A., Hielscher, T., Granzow, M., Bertsch, U., Egerer, G., Salwender, H., Blau, I. W., Weisel, K., Hillengass, J., Raab, M. S., Hose, D., Goldschmidt, H. & Jauch, A., 03.2016, In: HAEMATOLOGICA. 101, 3, p. e116-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

    Lin, Y., Qiu, L., Usmani, S., Joo, C. W., Costa, L., Derman, B., Du, J., Einsele, H., Fernandez de Larrea, C., Hajek, R., Ho, P. J., Kastritis, E., Martinez-Lopez, J., Mateos, M-V., Mikhael, J., Moreau, P., Nagarajan, C., Nooka, A., O'Dwyer, M., Schjesvold, F., Sidana, S., van de Donk, N. W., Weisel, K., Zweegman, S., Raje, N., Otero, P. R., Anderson, L. D., Kumar, S., Martin, T. & International Myeloma Working Group, 08.2024, In: LANCET ONCOL. 25, 8, p. e374-e387

    Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review

  13. Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma

    Kopp, H. G., Yildirim, S., Weisel, K. C., Kanz, L. & Vogel, W., 04.2009, In: J CANCER RES CLIN. 135, 4, p. 637-42 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Continuous lenalidomide treatment for newly diagnosed multiple myeloma

    Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jędrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C., Ben Yehuda, D., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C., Dimopoulos, M. A. & MM-015 Investigators, 10.05.2012, In: NEW ENGL J MED. 366, 19, p. 1759-69 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Corrigendum to "Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography" [Eur. J. Radiol. 85 (December (12)), 2016, 2195-2199]

    Schabel, C., Horger, M., Kum, S., Weisel, K., Fritz, J., Ioanoviciu, S. D. & Bier, G., 06.2018, In: EUR J RADIOL. 103, p. 163

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress

    Modemann, F., Ghandili, S., Schmiedel, S., Weisel, K., Bokemeyer, C. & Fiedler, W., 29.07.2022, In: CANCERS. 14, 15, 3711.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  17. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies

    Modemann, F., Niederwieser, C., Weisel, K., Bokemeyer, C., Fiedler, W. & Ghandili, S., 03.2022, In: LEUKEMIA LYMPHOMA. 63, 3, p. 664-671 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network

    Ludwig, H., Sonneveld, P., Facon, T., San-Miguel, J., Avet-Loiseau, H., Mohty, M., Mateos, M-V., Moreau, P., Cavo, M., Pawlyn, C., Zweegman, S., Engelhardt, M., Driessen, C., Cook, G., Dimopoulos, M. A., Gay, F., Einsele, H., Delforge, M., Caers, J., Weisel, K., Jackson, G., Garderet, L., van de Donk, N., Leleu, X., Goldschmidt, H., Beksac, M., Nijhof, I., Schreder, M., Abildgaard, N., Hajek, R., Zojer, N., Kastritis, E., Broijl, A., Schjesvold, F., Boccadoro, M. & Terpos, E., 12.2021, In: LANCET HAEMATOL. 8, 12, p. e934-e946

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  19. Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma

    Cope, S., Toor, K., Popoff, E., Fonseca, R., Landgren, O., Mateos, M-V., Weisel, K. & Jansen, J. P., 04.2020, In: VALUE HEALTH. 23, 4, p. 441-450 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Current Treatment Approaches to Newly Diagnosed Multiple Myeloma

    Ghandili, S., Weisel, K. C., Bokemeyer, C. & Leypoldt, L. B., 16.11.2021, In: ONCOL RES TREAT. 44, 12, p. 690-699 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  21. Cutaneous presentation of hematological malignancies

    Eberle, F. C., Metzler, G., Weisel, K. C., Berneburg, M. & Yazdi, A. S., 21.06.2013, In: EUR J DERMATOL. 23, 3, p. 372-7 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE

    Baertsch, M-A., Schlenzka, J., Lisenko, K., Krzykalla, J., Becker, N., Weisel, K., Noppeney, R., Martin, H., Lindemann, H. W., Haenel, M., Nogai, A., Scheid, C., Salwender, H., Fenk, R., Graeven, U., Reimer, P., Schmidt-Hieber, M., Goerner, M., Schmidt-Wolf, I. G. H., Klein, S., Ho, A. D., Goldschmidt, H. & Wuchter, P., 07.2017, In: EUR J HAEMATOL. 99, 1, p. 42-50 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

    Merz, M., Hielscher, T., Mai, E. K., Seckinger, A., Hose, D., Jauch, A., Sauer, S., Luntz, S., Bertsch, U., Raab, M. S., Neben, K., Salwender, H., Blau, I. W., Lindemann, H-W., Dürig, J., Scheid, C., Haenel, M., Weisel, K., Weber, T., Delorme, S., Goldschmidt, H. & Hillengass, J., 27.08.2019, In: BLOOD CANCER J. 9, 9, p. 71

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone

    Dimopoulos, M. A., Weisel, K. C., Song, K. W., Delforge, M., Karlin, L., Goldschmidt, H., Moreau, P., Banos, A., Oriol, A., Garderet, L., Cavo, M., Ivanova, V., Alegre, A., Martinez-Lopez, J., Chen, C., Spencer, A., Knop, S., Bahlis, N. J., Renner, C., Yu, X., Hong, K., Sternas, L., Jacques, C., Zaki, M. H. & San Miguel, J. F., 10.2015, In: HAEMATOLOGICA. 100, 10, p. 1327-33 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial

    Salwender, H., Weinhold, N., Benner, A., Miah, K., Merz, M., Haenel, M., Jehn, C., Mai, E., Menis, E., Blau, I., Scheid, C., Hose, D., Seckinger, A., Luntz, S., Besemer, B., Munder, M., Brossart, P., Glass, B., Lindemann, H-W., Weisel, K., Hanoun, C., Schnitzler, P., Klemm, S., Goldschmidt, H., Raab, M. & Elmaagacli, A., 12.2024, In: HEMATOLOGY. 29, 1, p. 2320006

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies

    Mateos, M-V., Spencer, A., Nooka, A. K., Pour, L., Weisel, K., Cavo, M., Laubach, J. P., Cook, G., Iida, S., Benboubker, L., Usmani, S. Z., Yoon, S-S., Bahlis, N. J., Chiu, C., Ukropec, J., Schecter, J. M., Qin, X., O' Rourke, L. & Dimopoulos, M. A., 2020, In: HAEMATOLOGICA. 105, 2, p. 468-477 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

    Palumbo, A., Chanan-Khan, A., Weisel, K., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M. V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, A., Sonneveld, P. & CASTOR Investigators, 25.08.2016, In: NEW ENGL J MED. 375, 8, p. 754-66 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial

    Leypoldt, L. B., Gavriatopoulou, M., Besemer, B., Salwender, H., Raab, M. S., Nogai, A., Khandanpour, C., Runde, V., Jauch, A., Zago, M., Martus, P., Goldschmidt, H., Bokemeyer, C., Dimopoulos, M. A. & Weisel, K. C., 21.09.2023, In: CANCERS. 15, 18, 4667.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk

    Weisel, K., Spencer, A., Lentzsch, S., Avet-Loiseau, H., Mark, T. M., Spicka, I., Masszi, T., Lauri, B., Levin, M-D., Bosi, A., Hungria, V., Cavo, M., Lee, J-J., Nooka, A., Quach, H., Munder, M., Lee, C., Barreto, W., Corradini, P., Min, C-K., Chanan-Khan, A. A., Horvath, N., Capra, M., Beksac, M., Ovilla, R., Jo, J-C., Shin, H-J., Sonneveld, P., Casneuf, T., DeAngelis, N., Amin, H., Ukropec, J., Kobos, R. & Mateos, M-V., 20.08.2020, In: J HEMATOL ONCOL. 13, 1, p. 115

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR

    Mateos, M-V., Sonneveld, P., Hungria, V., Nooka, A. K., Estell, J. A., Barreto, W., Corradini, P., Min, C-K., Medvedova, E., Weisel, K., Chiu, C., Schecter, J. M., Amin, H., Qin, X., Ukropec, J., Kobos, R. & Spencer, A., 09.10.2019, In: CL LYMPH MYELOM LEUK.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Daratumumab for patients with myeloma with early or late relapse after initial therapy: Subgroup Analysis of CASTOR and POLLUX

    Spencer, A., Moreau, P., Mateos, M. V., Goldschmidt, H., Suzuki, K., Levin, M-D., Sonneveld, P., Orlowski, R. Z., Yoon, S-S., Usmani, S. Z., Weisel, K. C., Reece, D., Ahmadi, T., Pei, H., Garvin Mayo, W., Gai, X., Carey, J., Bartlett, J. B., Carson, R. & Dimopoulos, M-A. A., 23.01.2024, In: BLOOD ADV. 8, 2, p. 388-398 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

    Facon, T., Kumar, S. K., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O'Dwyer, M., Perrot, A., Venner, C. P., Weisel, K., Mace, J. R., Raje, N., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Ahmadi, T., Wang, J., Van Rampelbergh, R., Uhlar, C. M., Tromp, B., Delioukina, M., Vermeulen, J. & Usmani, S. Z., 11.2021, In: LANCET ONCOL. 22, 11, p. 1582-1596 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

    Spencer, A., Lentzsch, S., Weisel, K., Avet-Loiseau, H., Mark, T. M., Spicka, I., Masszi, T., Lauri, B., Levin, M-D., Bosi, A., Hungria, V., Cavo, M., Lee, J-J., Nooka, A. K., Quach, H., Lee, C., Barreto, W., Corradini, P., Min, C-K., Scott, E. C., Chanan-Khan, A. A., Horvath, N., Capra, M., Beksac, M., Ovilla, R., Jo, J-C., Shin, H-J., Sonneveld, P., Soong, D., Casneuf, T., Chiu, C., Amin, H., Qi, M., Thiyagarajah, P., Sasser, A. K., Schecter, J. M. & Mateos, M-V., 12.2018, In: HAEMATOLOGICA. 103, 12, p. 2079-2087 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

    Facon, T., Kumar, S., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O'Dwyer, M., Perrot, A., Venner, C. P., Weisel, K., Mace, J. R., Raje, N., Attal, M., Tiab, M., Macro, M., Frenzel, L., Leleu, X., Ahmadi, T., Chiu, C., Wang, J., Van Rampelbergh, R., Uhlar, C. M., Kobos, R., Qi, M., Usmani, S. Z. & MAIA Trial Investigators, 30.05.2019, In: NEW ENGL J MED. 380, 22, p. 2104-2115 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA

    Facon, T., Cook, G., Usmani, S. Z., Hulin, C., Kumar, S., Plesner, T., Touzeau, C., Bahlis, N. J., Basu, S., Nahi, H., Goldschmidt, H., Quach, H., Mohty, M., Venner, C. P., Weisel, K., Raje, N., Hebraud, B., Belhadj-Merzoug, K., Benboubker, L., Decaux, O., Manier, S., Caillot, D., Ukropec, J., Pei, H., Van Rampelbergh, R., Uhlar, C. M., Kobos, R. & Zweegman, S., 04.2022, In: LEUKEMIA. 36, 4, p. 1066-1077 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

    Goldschmidt, H., Dimopoulos, M. A., Rajkumar, S. V., Weisel, K. C., Moreau, P., Chng, W-J., Mikala, G., Cavo, M., Ramasamy, K., Suryanarayan, K., Teng, Z., Labotka, R. & Mateos, M. V., 11.2020, In: LEUKEMIA. 34, 11, p. 3019-3027 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Development and Validation of A Conceptual Model of Multiple Myeloma

    Gonzalez-McQuire, S., Campioni, M., Bennison, C., Xu, W., Pantiri, K., Hensen, M., Weisel, K., Terpos, E. & Knop, S., 11.2015, In: VALUE HEALTH. 18, 7, p. A698

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Development of A Conceptual Model of Multiple Myeloma for Use In Economic Modelling: A Systematic Literature Review to Identify The Evidence Base

    Gonzalez-McQuire, S., Campioni, M., Bennison, C., Xu, W., Pantiri, K., Hensen, M., Weisel, K., Terpos, E. & Knop, S., 11.2015, In: VALUE HEALTH. 18, 7, p. A701

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making

    Gonzalez-McQuire, S., Dimopoulos, M-A., Weisel, K., Bouwmeester, W., Hájek, R., Campioni, M., Bennison, C., Xu, W., Pantiri, K., Hensen, M., Terpos, E. & Knop, S., 08.02.2019, In: MDM POLICY PRACT. 4, 1, p. 2381468318814253

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide

    Weisel, K. C., Böckeler, M., Bianchi, L., Terracciano, L. M., Mayer, F. & Kanz, L., 01.2009, In: International journal of hematology. 89, 1, p. 91-94 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma

    Dimopoulos, M. A., Jakubowiak, A. J., McCarthy, P. L., Orlowski, R. Z., Attal, M., Bladé, J., Goldschmidt, H., Weisel, K. C., Ramasamy, K., Zweegman, S., Spencer, A., Huang, J. S. Y., Lu, J., Sunami, K., Iida, S., Chng, W-J., Holstein, S. A., Rocci, A., Skacel, T., Labotka, R., Palumbo, A. & Anderson, K. C., 13.02.2020, In: BLOOD CANCER J. 10, 2, p. 17

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  42. Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacities

    Xue, X., Cai, Z., Seitz, G., Kanz, L., Weisel, K. C. & Möhle, R., 06.2007, In: ANN NY ACAD SCI. 1106, p. 180-9 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  43. DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma

    Kropff, M., Liebisch, P., Knop, S., Weisel, K., Wand, H., Gann, C-N., Berdel, W. E., Einsele, H. & Deutsche Studiengruppe Multiples Myelom, DSMM, 11.2009, In: ANN HEMATOL. 88, 11, p. 1125-30 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Dual-energy CT: virtual calcium subtraction for assessment of bone marrow involvement of the spine in multiple myeloma

    Thomas, C., Schabel, C., Krauss, B., Weisel, K., Bongers, M., Claussen, C. D. & Horger, M., 03.2015, In: AM J ROENTGENOL. 204, 3, p. W324-31

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Early M-protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma

    Yan, X., Xu, X. S., Weisel, K. C., Mateos, M-V., Sonneveld, P., Dimopoulos, M. A., Usmani, S. Z., Bahlis, N. J., Puchalski, T., Ukropec, J., Bellew, K., Ming, Q., Sun, S. & Zhou, H., 11.2020, In: CTS-CLIN TRANSL SCI. 13, 6, p. 1345-1354 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results

    Fenchel, M., Konaktchieva, M., Weisel, K., Kraus, S., Brodoefel, H., Claussen, C. D. & Horger, M., 12.2010, In: EUR RADIOL. 20, 12, p. 2899-906 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Effect of FLT3 inhibition on normal hematopoietic progenitor cells

    Weisel, K. C., Yildirim, S., Schweikle, E., Kanz, L. & Möhle, R., 06.2007, In: ANN NY ACAD SCI. 1106, p. 190-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  48. Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

    Facon, T., Niesvizky, R., Mateos, M-V., Siegel, D., Rosenbaum, C., Bringhen, S., Weisel, K., Ho, P. J., Ludwig, H., Kumar, S., Wang, K., Obreja, M., Yang, Z., Klippel, Z., Mezzi, K., Goldrick, A., Tekle, C. & Dimopoulos, M. A., 10.11.2020, In: BLOOD ADV. 4, 21, p. 5449-5459 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study

    Dimopoulos, M. A., Hungria, V. T. M., Radinoff, A., Delimpasi, S., Mikala, G., Masszi, T., Li, J., Capra, M., Maiolino, A., Pappa, V., Chraniuk, D., Osipov, I., Leleu, X., Low, M., Matsumoto, M., Sule, N., Li, M., McKeown, A., He, W., Bright, S., Currie, B., Perera, S., Boyle, J., Roy-Ghanta, S., Opalinska, J. & Weisel, K., 10.2023, In: LANCET HAEMATOL. 10, 10, p. e801-e812

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR

    Weisel, K., Mateos, M-V., Gay, F., Delforge, M., Cook, G., Szabo, Z., Desgraz, R., DeCosta, L. & Moreau, P., 06.2021, In: LEUKEMIA. 35, 6, p. 1732-1744 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next